Annual EBITDA
$255.96 M
-$125.83 M-32.96%
December 31, 2023
Summary
- As of February 24, 2025, IART annual EBITDA is $255.96 million, with the most recent change of -$125.83 million (-32.96%) on December 31, 2023.
- During the last 3 years, IART annual EBITDA has fallen by -$25.17 million (-8.95%).
- IART annual EBITDA is now -33.50% below its all-time high of $384.91 million, reached on December 31, 2021.
Performance
IART EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$34.97 M
-$5.27 M-13.10%
September 30, 2024
Summary
- As of February 24, 2025, IART quarterly EBITDA is $34.97 million, with the most recent change of -$5.27 million (-13.10%) on September 30, 2024.
- Over the past year, IART quarterly EBITDA has dropped by -$27.26 million (-43.80%).
- IART quarterly EBITDA is now -68.04% below its all-time high of $109.42 million, reached on March 31, 2021.
Performance
IART Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$187.77 M
-$27.26 M-12.68%
September 30, 2024
Summary
- As of February 24, 2025, IART TTM EBITDA is $187.77 million, with the most recent change of -$27.26 million (-12.68%) on September 30, 2024.
- Over the past year, IART TTM EBITDA has dropped by -$101.19 million (-35.02%).
- IART TTM EBITDA is now -51.22% below its all-time high of $384.91 million, reached on December 31, 2021.
Performance
IART TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IART EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.0% | -43.8% | -35.0% |
| 3 y3 years | -8.9% | -43.8% | -35.0% |
| 5 y5 years | +9.9% | -43.8% | -35.0% |
IART EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -33.5% | at low | -67.2% | at low | -51.2% | at low |
| 5 y | 5-year | -33.5% | +14.5% | -68.0% | at low | -51.2% | +0.3% |
| alltime | all time | -33.5% | +1588.1% | -68.0% | +277.6% | -51.2% | +998.4% |
Integra LifeSciences Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $34.97 M(-13.1%) | $187.77 M(-12.7%) |
| Jun 2024 | - | $40.24 M(+3.3%) | $215.03 M(-3.1%) |
| Mar 2024 | - | $38.96 M(-47.1%) | $221.90 M(-13.3%) |
| Dec 2023 | $255.96 M(-33.0%) | $73.59 M(+18.3%) | $255.96 M(-11.4%) |
| Sep 2023 | - | $62.23 M(+32.1%) | $288.96 M(-11.8%) |
| Jun 2023 | - | $47.11 M(-35.5%) | $327.81 M(-12.4%) |
| Mar 2023 | - | $73.02 M(-31.5%) | $374.11 M(-2.0%) |
| Dec 2022 | $381.79 M(-0.8%) | $106.60 M(+5.5%) | $381.79 M(+3.2%) |
| Sep 2022 | - | $101.07 M(+8.2%) | $369.85 M(+2.2%) |
| Jun 2022 | - | $93.42 M(+15.8%) | $361.88 M(+1.6%) |
| Mar 2022 | - | $80.69 M(-14.8%) | $356.18 M(-7.5%) |
| Dec 2021 | $384.91 M(+36.9%) | $94.66 M(+1.7%) | $384.91 M(+3.3%) |
| Sep 2021 | - | $93.10 M(+6.1%) | $372.69 M(-0.1%) |
| Jun 2021 | - | $87.73 M(-19.8%) | $372.93 M(+12.3%) |
| Mar 2021 | - | $109.42 M(+32.7%) | $332.21 M(+18.2%) |
| Dec 2020 | $281.13 M(+25.8%) | $82.44 M(-11.7%) | $281.13 M(+5.5%) |
| Sep 2020 | - | $93.33 M(+98.5%) | $266.43 M(+42.4%) |
| Jun 2020 | - | $47.01 M(-19.4%) | $187.15 M(-13.7%) |
| Mar 2020 | - | $58.34 M(-13.9%) | $216.80 M(-3.0%) |
| Dec 2019 | $223.52 M(-4.0%) | $67.75 M(+382.1%) | $223.52 M(+0.7%) |
| Sep 2019 | - | $14.05 M(-81.7%) | $221.90 M(-15.4%) |
| Jun 2019 | - | $76.66 M(+17.8%) | $262.40 M(+8.0%) |
| Mar 2019 | - | $65.06 M(-1.6%) | $242.88 M(+4.3%) |
| Dec 2018 | $232.82 M(+72.0%) | $66.13 M(+21.2%) | $232.82 M(+13.2%) |
| Sep 2018 | - | $54.55 M(-4.5%) | $205.70 M(+13.0%) |
| Jun 2018 | - | $57.14 M(+3.9%) | $182.12 M(+13.3%) |
| Mar 2018 | - | $55.00 M(+41.0%) | $160.75 M(+18.8%) |
| Dec 2017 | $135.35 M(-28.3%) | $39.01 M(+26.0%) | $135.35 M(-13.6%) |
| Sep 2017 | - | $30.96 M(-13.5%) | $156.67 M(-10.5%) |
| Jun 2017 | - | $35.78 M(+20.9%) | $175.08 M(-2.1%) |
| Mar 2017 | - | $29.59 M(-51.0%) | $178.85 M(-5.3%) |
| Dec 2016 | $188.87 M(+32.0%) | $60.34 M(+22.2%) | $188.88 M(+9.5%) |
| Sep 2016 | - | $49.38 M(+24.9%) | $172.43 M(+14.1%) |
| Jun 2016 | - | $39.55 M(-0.2%) | $151.12 M(+2.4%) |
| Mar 2016 | - | $39.62 M(-9.7%) | $147.63 M(+3.2%) |
| Dec 2015 | $143.07 M(+25.5%) | $43.89 M(+56.4%) | $143.07 M(+1.8%) |
| Sep 2015 | - | $28.06 M(-22.2%) | $140.48 M(+4.7%) |
| Jun 2015 | - | $36.05 M(+2.8%) | $134.17 M(+6.6%) |
| Mar 2015 | - | $35.06 M(-15.1%) | $125.89 M(+10.5%) |
| Dec 2014 | $113.97 M(+63.9%) | $41.30 M(+89.9%) | $113.90 M(-17.1%) |
| Sep 2014 | - | $21.75 M(-21.7%) | $137.47 M(+43.2%) |
| Jun 2014 | - | $27.77 M(+20.3%) | $96.03 M(+11.1%) |
| Mar 2014 | - | $23.08 M(-64.4%) | $86.44 M(+20.6%) |
| Dec 2013 | $69.52 M(-45.2%) | $64.88 M(-429.4%) | $71.64 M(+86.0%) |
| Sep 2013 | - | -$19.70 M(-208.4%) | $38.52 M(-57.8%) |
| Jun 2013 | - | $18.17 M(+119.3%) | $91.34 M(-13.1%) |
| Mar 2013 | - | $8.29 M(-73.9%) | $105.07 M(-17.2%) |
| Dec 2012 | $126.88 M(+19.4%) | $31.76 M(-4.1%) | $126.88 M(+9.2%) |
| Sep 2012 | - | $33.12 M(+3.8%) | $116.23 M(+1.2%) |
| Jun 2012 | - | $31.90 M(+6.0%) | $114.83 M(+8.2%) |
| Mar 2012 | - | $30.10 M(+42.6%) | $106.14 M(-0.2%) |
| Dec 2011 | $106.31 M(-23.9%) | $21.11 M(-33.5%) | $106.31 M(-11.6%) |
| Sep 2011 | - | $31.73 M(+36.7%) | $120.27 M(-3.7%) |
| Jun 2011 | - | $23.21 M(-23.3%) | $124.92 M(-8.6%) |
| Mar 2011 | - | $30.26 M(-13.7%) | $136.62 M(-2.2%) |
| Dec 2010 | $139.64 M(+2.6%) | $35.07 M(-3.6%) | $139.64 M(-3.5%) |
| Sep 2010 | - | $36.38 M(+4.2%) | $144.70 M(+1.9%) |
| Jun 2010 | - | $34.92 M(+4.9%) | $141.93 M(+2.1%) |
| Mar 2010 | - | $33.28 M(-17.1%) | $139.04 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $136.07 M(+71.5%) | $40.13 M(+19.4%) | $136.07 M(+4.0%) |
| Sep 2009 | - | $33.61 M(+4.9%) | $130.89 M(+61.4%) |
| Jun 2009 | - | $32.02 M(+5.7%) | $81.07 M(-0.4%) |
| Mar 2009 | - | $30.31 M(-13.3%) | $81.42 M(+2.6%) |
| Dec 2008 | $79.34 M(-15.9%) | $34.95 M(-315.6%) | $79.34 M(+18.5%) |
| Sep 2008 | - | -$16.21 M(-150.1%) | $66.95 M(-38.1%) |
| Jun 2008 | - | $32.38 M(+14.7%) | $108.09 M(+7.8%) |
| Mar 2008 | - | $28.22 M(+25.1%) | $100.29 M(+6.3%) |
| Dec 2007 | $94.33 M(+17.6%) | $22.56 M(-9.5%) | $94.33 M(-3.7%) |
| Sep 2007 | - | $24.93 M(+1.5%) | $97.94 M(+6.2%) |
| Jun 2007 | - | $24.57 M(+10.4%) | $92.19 M(+8.3%) |
| Mar 2007 | - | $22.26 M(-15.0%) | $85.16 M(+6.2%) |
| Dec 2006 | $80.22 M(+15.7%) | $26.17 M(+36.4%) | $80.22 M(+11.2%) |
| Sep 2006 | - | $19.18 M(+9.3%) | $72.15 M(-0.2%) |
| Jun 2006 | - | $17.55 M(+1.3%) | $72.28 M(+2.9%) |
| Mar 2006 | - | $17.32 M(-4.3%) | $70.22 M(+1.3%) |
| Dec 2005 | $69.33 M(+90.6%) | $18.10 M(-6.2%) | $69.33 M(+1.8%) |
| Sep 2005 | - | $19.31 M(+24.6%) | $68.11 M(+71.5%) |
| Jun 2005 | - | $15.49 M(-5.7%) | $39.72 M(+3.7%) |
| Mar 2005 | - | $16.42 M(-2.7%) | $38.32 M(+5.3%) |
| Dec 2004 | $36.37 M(-25.3%) | $16.88 M(-286.0%) | $36.37 M(+3.2%) |
| Sep 2004 | - | -$9.07 M(-164.4%) | $35.25 M(-38.7%) |
| Jun 2004 | - | $14.09 M(-2.7%) | $57.55 M(+6.9%) |
| Mar 2004 | - | $14.48 M(-8.2%) | $53.81 M(+10.5%) |
| Dec 2003 | $48.69 M(+69.8%) | $15.76 M(+19.2%) | $48.69 M(+16.8%) |
| Sep 2003 | - | $13.22 M(+27.7%) | $41.69 M(+21.4%) |
| Jun 2003 | - | $10.36 M(+10.7%) | $34.35 M(+10.4%) |
| Mar 2003 | - | $9.35 M(+6.7%) | $31.13 M(+8.5%) |
| Dec 2002 | $28.68 M(+39.6%) | $8.76 M(+49.1%) | $28.68 M(+8.9%) |
| Sep 2002 | - | $5.88 M(-17.6%) | $26.32 M(+1.7%) |
| Jun 2002 | - | $7.13 M(+3.3%) | $25.89 M(+9.5%) |
| Mar 2002 | - | $6.90 M(+7.7%) | $23.63 M(+4.3%) |
| Dec 2001 | $20.54 M(-255.5%) | $6.41 M(+17.8%) | $22.65 M(+433.3%) |
| Sep 2001 | - | $5.44 M(+11.5%) | $4.25 M(-834.9%) |
| Jun 2001 | - | $4.88 M(-17.6%) | -$578.00 K(-87.7%) |
| Mar 2001 | - | $5.92 M(-149.4%) | -$4.68 M(-49.0%) |
| Dec 2000 | -$13.21 M(+6.5%) | -$12.00 M(-2053.7%) | -$9.19 M(+936.8%) |
| Sep 2000 | - | $614.00 K(-20.7%) | -$886.00 K(-78.9%) |
| Jun 2000 | - | $774.00 K(-45.6%) | -$4.20 M(-57.0%) |
| Mar 2000 | - | $1.42 M(-138.5%) | -$9.77 M(-32.1%) |
| Dec 1999 | -$12.40 M(-25.3%) | -$3.70 M(+36.9%) | -$14.40 M(-16.8%) |
| Sep 1999 | - | -$2.70 M(-43.8%) | -$17.30 M(-2.3%) |
| Jun 1999 | - | -$4.80 M(+50.0%) | -$17.70 M(+4.7%) |
| Mar 1999 | - | -$3.20 M(-51.5%) | -$16.90 M(+1.2%) |
| Dec 1998 | -$16.60 M(-3.5%) | -$6.60 M(+113.0%) | -$16.70 M(-20.1%) |
| Sep 1998 | - | -$3.10 M(-22.5%) | -$20.90 M(+3.5%) |
| Jun 1998 | - | -$4.00 M(+33.3%) | -$20.20 M(+10.4%) |
| Mar 1998 | - | -$3.00 M(-72.2%) | -$18.30 M(+7.0%) |
| Dec 1997 | -$17.20 M(+129.3%) | -$10.80 M(+350.0%) | -$17.10 M(+101.2%) |
| Sep 1997 | - | -$2.40 M(+14.3%) | -$8.50 M(+4.9%) |
| Jun 1997 | - | -$2.10 M(+16.7%) | -$8.10 M(+8.0%) |
| Mar 1997 | - | -$1.80 M(-18.2%) | -$7.50 M(+4.2%) |
| Dec 1996 | -$7.50 M(+63.0%) | -$2.20 M(+10.0%) | -$7.20 M(+7.5%) |
| Sep 1996 | - | -$2.00 M(+33.3%) | -$6.70 M(+15.5%) |
| Jun 1996 | - | -$1.50 M(0.0%) | -$5.80 M(+190.0%) |
| Mar 1996 | - | -$1.50 M(-11.8%) | -$2.00 M(-211.1%) |
| Dec 1995 | -$4.60 M | -$1.70 M(+54.5%) | $1.80 M(-48.6%) |
| Sep 1995 | - | -$1.10 M(-147.8%) | $3.50 M(-23.9%) |
| Jun 1995 | - | $2.30 M(0.0%) | $4.60 M(+100.0%) |
| Mar 1995 | - | $2.30 M | $2.30 M |
FAQ
- What is Integra LifeSciences Holdings annual EBITDA?
- What is the all time high annual EBITDA for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual EBITDA year-on-year change?
- What is Integra LifeSciences Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly EBITDA year-on-year change?
- What is Integra LifeSciences Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings TTM EBITDA year-on-year change?
What is Integra LifeSciences Holdings annual EBITDA?
The current annual EBITDA of IART is $255.96 M
What is the all time high annual EBITDA for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual EBITDA is $384.91 M
What is Integra LifeSciences Holdings annual EBITDA year-on-year change?
Over the past year, IART annual EBITDA has changed by -$125.83 M (-32.96%)
What is Integra LifeSciences Holdings quarterly EBITDA?
The current quarterly EBITDA of IART is $34.97 M
What is the all time high quarterly EBITDA for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly EBITDA is $109.42 M
What is Integra LifeSciences Holdings quarterly EBITDA year-on-year change?
Over the past year, IART quarterly EBITDA has changed by -$27.26 M (-43.80%)
What is Integra LifeSciences Holdings TTM EBITDA?
The current TTM EBITDA of IART is $187.77 M
What is the all time high TTM EBITDA for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high TTM EBITDA is $384.91 M
What is Integra LifeSciences Holdings TTM EBITDA year-on-year change?
Over the past year, IART TTM EBITDA has changed by -$101.19 M (-35.02%)